iSAM Funds UK Ltd Sells 6,348 Shares of Genpact Limited (NYSE:G)

iSAM Funds UK Ltd decreased its stake in shares of Genpact Limited (NYSE:G - Free Report) by 55.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,056 shares of the business services provider's stock after selling 6,348 shares during the period. iSAM Funds UK Ltd's holdings in Genpact were worth $217,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. Squarepoint Ops LLC boosted its stake in Genpact by 847.8% during the fourth quarter. Squarepoint Ops LLC now owns 354,549 shares of the business services provider's stock worth $15,228,000 after acquiring an additional 401,962 shares in the last quarter. Teza Capital Management LLC boosted its stake in Genpact by 405.0% during the fourth quarter. Teza Capital Management LLC now owns 79,623 shares of the business services provider's stock worth $3,420,000 after acquiring an additional 63,855 shares in the last quarter. State of Wyoming boosted its stake in Genpact by 302.7% during the fourth quarter. State of Wyoming now owns 6,536 shares of the business services provider's stock worth $281,000 after acquiring an additional 4,913 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new stake in Genpact during the fourth quarter worth about $584,000. Finally, ProShare Advisors LLC boosted its stake in Genpact by 6.2% during the fourth quarter. ProShare Advisors LLC now owns 7,591 shares of the business services provider's stock worth $326,000 after acquiring an additional 445 shares in the last quarter. Institutional investors own 96.03% of the company's stock.

Analysts Set New Price Targets

G has been the subject of several recent analyst reports. Mizuho lifted their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC decreased their target price on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Robert W. Baird decreased their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $50.71.

Insider Activity

In related news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Nicholas C. Gangestad bought 2,000 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the transaction, the director now directly owns 2,000 shares of the company's stock, valued at $87,940. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is owned by corporate insiders.

Genpact Stock Performance

Shares of G traded down $0.02 during mid-day trading on Friday, hitting $43.50. 945,783 shares of the company traded hands, compared to its average volume of 1,369,261. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The stock has a 50-day moving average price of $47.42 and a two-hundred day moving average price of $47.36. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76. The stock has a market cap of $7.61 billion, a price-to-earnings ratio of 15.32, a P/E/G ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The firm had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. During the same period in the previous year, the company earned $0.73 earnings per share. The firm's quarterly revenue was up 7.4% on a year-over-year basis. Equities analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.